Happy to talk about it other name i was mentioning was Lagardere...see Mediobanca comment below
Mediobanca sees Mediaset as possible target for Vivendi MS.MI SKYB.L VIV.PA - RTRS
09-Apr-2015 15:09 ** Shares in Italian TV company Mediaset MS.MI rise to their highest level since March 2011, up 2.6 pct and outperform European media stocks .SXMP which is up 1.2 pct ** Mediobanca Securities says Mediaset, controlled by former prime minister Silvio Berlusconi, could be "an interesting strategic option" for French media group Vivendi VIV.PA ** It says "a deal in paper, cash, or a mix of the two would be feasible", confirming its outperform rating and 4.74 euro price target based on fundamentals ** The Sky SKYB.L M&A deal "could translate into a need of the other names to build up an international alternative in the mid-term", it says
DAVID FABER @davidfaber Intel has ended talks to acquire Altera $INTC made all cash offer in "low $50's and was rejected. Talks has taken place for months- sources.
In reaction to disappointing earnings/guidance: MG -6.3%, BBBY -3.2%, AA -2.6%, ATNY -2.4%, ZUMZ -1.2%, STLY -1%, COST -1%, RECN -0.7%
Select metals/mining stocks trading lower: HMY -3.1%, SLV -1.3%, BHP -1.2%, RIO -0.9%, MT -0.8%, AU -0.7%, GDX -0.5%
Other news: ZNGA -10.3% (announced that current CEO Don Mattrick will depart the Company and the Board effective April 8, 2015; Mark Pincus, Zynga's founder and chairman, will return to the role of Chief Executive Officer), EVRY -5.6% (announced it is moving forward with the restructuring plan and has filed voluntary Chapter 11 petitions), MEMP -5.1% (announced secondary public offering of ~4.66 mln common units representing limited partner interests owned by MRD Holdco LLC), QURE -2.5% (discloses update to risk factors statement with respect to the ongoing post-approval review of its Glybera program by the European Medicines Agency), GPT -2.4% (announced public offering of 7 mln shares of common stock), SHPG -2.2% (reports topline results from first of three placebo-controlled Phase 2 studies of SHP625 in children with alagille syndrome; did not meet the primary or secondary endpoints), RDS.A -1.9% (cont weakness following merger news with BG Group), SRC -1.1% (announced commencement of a public offering of 20 million shares of common stock), RGLS -0.8% (filed for ~3.27 mln share common stock offering by selling shareholders)
Analyst comments: CLF -4.4% (downgraded to Underperform from Market Perform at BMO Capital ), VALE -1.3% (downgraded to Underperform from Market Perform at BMO Capital ), TCK -1.1% (downgraded to Neutral from Outperform at Credit Suisse), EMC -0.8% (downgraded to Sector Perform at FBN Securities)
In reaction to strong earnings/guidance: APOG +7.4%, MSTX +6.6%, PIR +4.7%, WBA +3.4%, LB +1.4%, DDC +0.8%
M&A news: INFN +2% (announces offer to acquire Transmode)
Select China related names showing strength: MCP +13.5%, SHI +12.4%, FENG +8.2%, SFUN +6.2%, PTR +3.8%, LEJU +3.4%, WYNN +2.4%, HSBC +1.1%, .
Select oil/gas related names showing strength: RIG +1.4%, PBR +1.2%, STO +1%, TOT +0.8%
Other news: NVGN +44.3% (announced that studies conducted at The University of Queensland Diamantina Institute revealed that experimental drug, Anisina, killed melanoma cells irrespective of their mutational status), WPCS +35.1% (announced that its domestic operation was awarded $14.4 million in new contracts during the month of March 2015), MPET +21.8% (continued volatility in the name pre-mkt), FNJN +8.1% (announced thaty have signed a patent license agreement), AMCN +8.1% (granted wi-fi concession right on ordinary trains operated by Shanghai Railway Bureau), INO +7.9% (higher following CEO appearance on CNBC discussing $45 mln Ebola grant, also announces its Immunotherapy activates robust In Vivo T Cell responses in head and neck cancer patients), SLTD +7.8% (Solar3D's SUNworks division achieves record sales in March), MUX +5% (provides robbery update; maintains production guidance), TASR +4.1% (announces an order from the London Police Department for 178 AXON body cameras; the order was received and shipped in the first quarter of 2015), DBVT +3.5% (receives FDA Breakthrough Therapy Designation for Viaskin Peanut for the treatment of peanut allergy in children), CTP +2.8% (announced new debt financing amendment to credit facility; co intends to file Form 10-K on or before April 15, 2015), UAL +2.7% (reports March 2015 operational results), BAM +1.9% (announced three-for-two stock split and dividend increase of 6% per share), WG +1.5% (KKR Credit Advisors disclosed 16.6% active stake in 13D filing), BIDU +1.2% (Putian Healthcare Industry Chamber of Commerce has suspended its boycott of Baidu's advertising service, according to reports), BABA +1.1% (Alibaba and COST issue joint statement regarding false claims of distribution channels of Costco products sold in China)
Analyst comments: PLUG +2.4% (initiated with a Equal-Weight at Morgan Stanley; tgt $3), RIBT +2.2% (initiated with a Buy at Maxim Group; tgt $7), IHG +1.4% (upgraded to Hold from Underperform at Jefferies), CGIX +1.4% (initiated with a Buy at Janney), XENT +1.1% (initiated with a Buy at CRT Capital), DNKN +0.7% (added to U.S. Focus List at Credit Suisse), SWN +0.6% (upgraded to Buy at Johnson Rice
)
- Net sales for the beer segment increased 11% primarily due to volume growth driven by continued strong consumer demand.
- Wine and spirits net sales on a constant currency basis increased two%. This reflects favorable mix and distributor performance payments, partially offset by lower volume.
- For fiscal 2016, the beer business is targeting mid-single digit volume growth, high-single digit net sales growth and 10 - 12% operating income growth.
- For the wine and spirits business, the company expects net sales and operating income growth to be in the low-to-mid-single digit range.